Literature DB >> 33504912

Circulating neurotrophins and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and during sympathetic challenge: the SABPA study.

Roland von Känel1,2, Mark Hamer3, Annemarie Wentzel4, Leoné Malan4.   

Abstract

Sympathetic activation may trigger acute coronary syndromes. We examined the relation between circulating neurotrophic factors and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and in response to acute mental stress to establish a brain-heart link. In 409 black and white South Africans, brain-derived neurotrophic factor (BDNF) and fibrinolytic measures were assessed at baseline. Glial cell-derived neurotrophic factor (GDNF), S100 calcium-binding protein (S100B), von Willebrand factor (VWF), fibrinogen and D-dimer were assessed at baseline and 10 min after the Stroop test. Neurotrophins were regressed on hemostatic measures adjusting for demographics, comorbidities, cardiometabolic factors and health behaviors. Higher baseline BDNF was associated with greater stress-induced increase in fibrinogen (p = 0.003) and lower D-dimer increase (p = 0.016). Higher baseline S100B was significantly associated with higher baseline VWF (p = 0.031) and lower fibrinogen increase (p = 0.048). Lower baseline GDNF was associated with higher baseline VWF (p = 0.035) but lower VWF increase (p = 0.001). Greater GDNF (p = 0.006) and S100B (p = 0.042) increases were associated with lower VWF increase. All associations showed small-to-moderate effect sizes. Neurotrophins and fibrinolytic factors showed no significant associations. The findings support the existence of a peripheral neurothrophin-hemostasis interaction of small-to-moderate clinical relevance. The implications for atherothrombotic cardiovascular disease need further exploration.

Entities:  

Year:  2021        PMID: 33504912      PMCID: PMC7841151          DOI: 10.1038/s41598-021-81946-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

Review 1.  Thrombosis and acute coronary syndrome.

Authors:  Rosanna Abbate; Gabriele Cioni; Ilaria Ricci; Marco Miranda; Anna Maria Gori
Journal:  Thromb Res       Date:  2012-01-24       Impact factor: 3.944

Review 2.  The hemostatic system as a modulator of atherosclerosis.

Authors:  Julian Ilcheff Borissoff; Henri M H Spronk; Hugo ten Cate
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

3.  Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease.

Authors:  Junya Ejiri; Nobutaka Inoue; Seiichi Kobayashi; Rio Shiraki; Kazunori Otsui; Tomoyuki Honjo; Motonori Takahashi; Yoshitaka Ohashi; Shinobu Ichikawa; Mitsuyasu Terashima; Takao Mori; Kojiro Awano; Toshiro Shinke; Junya Shite; Ken-ichi Hirata; Hiroshi Yokozaki; Seinosuke Kawashima; Mitsuhiro Yokoyama
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

4.  Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury.

Authors:  Xue Ying Cai; Lin Lu; Ya Nan Wang; Cao Jin; Rui Yan Zhang; Qi Zhang; Qiu Jing Chen; Wei Feng Shen
Journal:  Atherosclerosis       Date:  2011-05-27       Impact factor: 5.162

5.  Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters.

Authors:  Maria Skibinska; Pawel Kapelski; Joanna Pawlak; Aleksandra Rajewska-Rager; Monika Dmitrzak-Weglarz; Aleksandra Szczepankiewicz; Piotr Czerski; Joanna Twarowska-Hauser
Journal:  Psychiatry Res       Date:  2017-07-06       Impact factor: 3.222

Review 6.  The S100B story: from biomarker to active factor in neural injury.

Authors:  Fabrizio Michetti; Nadia D'Ambrosi; Amelia Toesca; Maria Ausiliatrice Puglisi; Alessia Serrano; Elisa Marchese; Valentina Corvino; Maria Concetta Geloso
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

Review 7.  The impact of blood coagulability on atherosclerosis and cardiovascular disease.

Authors:  R Loeffen; H M H Spronk; H ten Cate
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

8.  Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.

Authors:  Hong Jin; Yifei Chen; Bilei Wang; Yi Zhu; Long Chen; Xiqiong Han; Genshan Ma; Naifeng Liu
Journal:  BMC Cardiovasc Disord       Date:  2018-02-06       Impact factor: 2.298

Review 9.  Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses.

Authors:  Peter Willeit; Alexander Thompson; Thor Aspelund; Ann Rumley; Gudny Eiriksdottir; Gordon Lowe; Vilmundur Gudnason; Emanuele Di Angelantonio
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.

Authors:  Bernhard M Kaess; Sarah R Preis; Wolfgang Lieb; Alexa S Beiser; Qiong Yang; Tai C Chen; Christian Hengstenberg; Jeanette Erdmann; Heribert Schunkert; Sudha Seshadri; Ramachandran S Vasan; Themistocles L Assimes; Panos Deloukas; Hilma Holm; Sekar Kathiresan; Inke R König; Ruth McPherson; Muredach P Reilly; Robert Roberts; Nilesh J Samani; Alexandre F R Stewart
Journal:  J Am Heart Assoc       Date:  2015-03-11       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.